RxDoctor Payments Data

Amy Daniel, MD

Family Medicine · Cabot, ARNPI 1316963234

Payments from drug & device makers

$2,026in general payments, 2019–2025

Across 144 payments — averaging $14.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$273
  • Novo Nordisk$235
  • AstraZeneca$201
  • GSK$181
  • Lilly USA, LLC$173
  • Pfizer$161
  • plus $802 from 17 others

What the payments were for

  • Food & beverage$2,00499%
  • Education$221%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,026 in reported general payments places this provider in the 70th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$18,959
Medicare patients
150
Services billed
338

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XolairOmalizumab13$70,862
OzempicSemaglutide13$12,773
EliquisApixaban20$10,367
FarxigaDapagliflozin Propanediol17$9,267
JanuviaSitagliptin Phosphate12$7,962
XareltoRivaroxaban12$6,396
Albuterol Sulfate HfaAlbuterol Sulfate80$1,893
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,303
Gabapentin79$1,076
Atorvastatin Calcium89$943
Omeprazole104$874
Naproxen16$572
Hydroxyzine Hcl16$412
Duloxetine Hcl26$387
Oxybutynin Chloride ErOxybutynin Chloride16$379

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$235$12,77313 claims
PfizerEliquis$161$10,36720 claims
AstraZenecaFarxiga$201$9,26717 claims
MerckJanuvia$75$7,96212 claims
Johnson & JohnsonXarelto$15$6,39612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Cabot

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →